Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases

Annals of Clinical and Laboratory Science

Volumn 36, Issue 3, 2006, Pages 262-266

  Park, Yeon Joon ^a   Oh, Eun Jee ^a   Park, Jong Won ^a   Kim, Myungshin ^a   Han, Kyungja ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

ECP Eo ratio; Eosinophil cationic protein (ECP); Eosinophils; Hypereosinophilic syndrome; Interleukin 5

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 5;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CANCER DIAGNOSIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL COUNT; GASTROINTESTINAL DISEASE; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; INFLAMMATION; LUNG CANCER; LUNG DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BONE MARROW EXAMINATION; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILIA; HUMANS; INTERLEUKIN-5;

EID: 33748272938     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brito-Babapulle F. Eosinophilia, including the idiopathic hypereosinophilic syndrome. BrJ Haematol 2003;121: 203-223.
2. Roufosse F, Cogan E, Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 2004;59:673-689.
3. Tefferi A. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc 2005;80:75-83.
4. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989;170:343-348.
5. Ionescu MA, Rivet J, Daneshpouy M, Briere J, Morel P, Janin A. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol 2005;52:32-39.
6. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-3109.
7. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003;54:169-184.
8. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172-1186.
9. Bobbio-Pallavicini E, Confalonieri M, Tacconi F, Mainardi E, Della Porta R, Ceccato D, et al. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions. Panminerva Med 1998;40:186-190.
10. Trulson A, Nilsson S, Venge P. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol 1997;98:312-314.
11. Fujitaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y. Significance of the eosinophil cationic protein/ eosinophil count ratio in asthmatic patients: its relationship to disease severity. Ann Allergy Asthma Immunol 2001;86:323-329.
12. Stelmach I, Majak P, Grzelewski T, Jerzynska J, Juralowicz D, Stelmach W, et al. The ECP/Eo count ratio in children with asthma. J Asthma 2004;41:539-546.
13. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701-709.
14. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-2547.
15. Gotlib J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol 2005;114:7-25.
16. Molin D, Glimelius B, Sundstrom C, Venge P, Enblad G. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease. Leuk Lymphoma 2001;42:457-465.
17. Lowe D, Jorizzo J, Hutt MS. Tumour-associated eosinophilia: a review. J Clin Pathol 1981;34:1343-1348.
18. Liu CM, Ko JJ, Shun CT, Hsiao TY, Sheen TS. Soluble adhesion molecules and cytokines in tumor-associated tissue eosinophilia of nasopharyngeal carcinoma. Acta Otolaryngol 2001;121:534-538.
19. Fishel RS, Farnen JP, Hanson CA, Silver SM, Emerson SG. Acute lymphoblastic leukemia with eosinophilia. Medicine (Baltimore) 1990;69:232-243.
20. Watanabe K, Shinbo T, Kojima M, Naito M, Tanahashi N, Nara M. B-cell lymphoma associated with eosinophilia. Cancer 1989;64:1682-1685.
21. Berki T, David M, Bone B, Losonczy H, Vass J, Nemeth P. New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states. Pathol Oncol Res 2001;7:292-297.